Approximately one-fourth of TAVR candidates manifested symptoms of insomnia, a condition autonomously correlated with heightened mortality and morbidity following the TAVR procedure. The optimal strategy for addressing insomnia in TAVR candidates constitutes a paramount consideration for future interventions.
Keyphrases
- aortic stenosis
- aortic valve replacement
- aortic valve
- transcatheter aortic valve replacement
- sleep quality
- transcatheter aortic valve implantation
- ejection fraction
- left ventricular
- coronary artery disease
- physical activity
- cardiovascular events
- minimally invasive
- heart failure
- current status
- atrial fibrillation
- cardiovascular disease